Genome editing technologies and their potential to treat neurologic disease.
作者信息
Madigan Nicolas N, Staff Nathan P, Windebank Anthony J, Benarroch Eduardo E
机构信息
From the Department of Neurology, Mayo Clinic, Rochester, MN.
出版信息
Neurology. 2017 Oct 17;89(16):1739-1748. doi: 10.1212/WNL.0000000000004558. Epub 2017 Sep 20.
Abstract
摘要
相似文献
1
Genome editing technologies and their potential to treat neurologic disease.基因组编辑技术及其治疗神经系统疾病的潜力。
Neurology. 2017 Oct 17;89(16):1739-1748. doi: 10.1212/WNL.0000000000004558. Epub 2017 Sep 20.
2
Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.将工程核酸酶与腺相关病毒载体相结合用于治疗性基因编辑。
Adv Exp Med Biol. 2017;1016:29-42. doi: 10.1007/978-3-319-63904-8_2.
3
[CRISPR-Cas system as molecular scissors for gene therapy].[作为基因治疗分子剪刀的CRISPR-Cas系统]
Z Rheumatol. 2017 Feb;76(1):46-49. doi: 10.1007/s00393-017-0267-7.
4
On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals.CRISPR-Cas 技术的起源：从原核生物到哺乳动物。
Trends Microbiol. 2016 Oct;24(10):811-820. doi: 10.1016/j.tim.2016.06.005. Epub 2016 Jul 9.
5
[CRISPR/Cas9 and gene therapy].[CRISPR/Cas9与基因治疗]
Medicina (B Aires). 2017;77(5):405-409.
6
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.基于 CRISPR/Cas9 的基因组编辑在疾病建模和治疗中的应用：非病毒递送的挑战和机遇。
Chem Rev. 2017 Aug 9;117(15):9874-9906. doi: 10.1021/acs.chemrev.6b00799. Epub 2017 Jun 22.
7
Viral Vectors, Engineered Cells and the CRISPR Revolution.病毒载体、工程细胞与CRISPR革命
Adv Exp Med Biol. 2017;1016:3-27. doi: 10.1007/978-3-319-63904-8_1.
8
CRISPR/Cas9-Based Genome Editing in Plants.基于CRISPR/Cas9的植物基因组编辑
Prog Mol Biol Transl Sci. 2017;149:133-150. doi: 10.1016/bs.pmbts.2017.03.008. Epub 2017 May 12.
9
Gene Editing With TALEN and CRISPR/Cas in Rice.利用TALEN和CRISPR/Cas对水稻进行基因编辑
Prog Mol Biol Transl Sci. 2017;149:81-98. doi: 10.1016/bs.pmbts.2017.04.006. Epub 2017 May 24.
10
Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.成年小鼠视网膜体内CRISPR/Cas编辑方法
Methods Mol Biol. 2018;1715:113-133. doi: 10.1007/978-1-4939-7522-8_9.
引用本文的文献
1
DNA aptamers that modulate biological activity of model neurons.调节模型神经元生物活性的DNA适配体。
Mol Ther Nucleic Acids. 2024 Nov 16;35(4):102392. doi: 10.1016/j.omtn.2024.102392. eCollection 2024 Dec 10.
2
Recent Scientific Breakthroughs Applying CRISPR Gene Editing in Neurological Disorders.近期在神经疾病中应用CRISPR基因编辑技术的科学突破。
Dela J Public Health. 2021 Dec 15;7(5):6-8. doi: 10.32481/djph.2021.12.004. eCollection 2021 Dec.
3
Protein and mRNA Delivery Enabled by Cholesteryl-Based Biodegradable Lipidoid Nanoparticles.基于胆固醇的可生物降解脂质纳米颗粒实现蛋白质和 mRNA 的递送。
Angew Chem Int Ed Engl. 2020 Aug 24;59(35):14957-14964. doi: 10.1002/anie.202004994. Epub 2020 Jun 15.
本文引用的文献
1
Correction of a pathogenic gene mutation in human embryos.人类胚胎中致病基因突变的纠正。
Nature. 2017 Aug 24;548(7668):413-419. doi: 10.1038/nature23305. Epub 2017 Aug 2.
2
From transplanting Schwann cells in experimental rat spinal cord injury to their transplantation into human injured spinal cord in clinical trials.从在实验性大鼠脊髓损伤中移植施万细胞到在临床试验中将其移植到人类脊髓损伤患者体内。
Prog Brain Res. 2017;231:107-133. doi: 10.1016/bs.pbr.2016.12.012. Epub 2017 Mar 31.
3
BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks.BLISS 是一种用于全基因组范围内 DNA 双链断裂分析的通用且定量的方法。
Nat Commun. 2017 May 12;8:15058. doi: 10.1038/ncomms15058.
4
Chemotherapy-induced peripheral neuropathy: A current review.化疗引起的周围神经病变：当前综述
Ann Neurol. 2017 Jun;81(6):772-781. doi: 10.1002/ana.24951. Epub 2017 Jun 5.
5
RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.功能正交的VI-A型CRISPR-Cas酶对RNA的靶向作用
Mol Cell. 2017 May 4;66(3):373-383.e3. doi: 10.1016/j.molcel.2017.04.008.
6
Genome editing via delivery of Cas9 ribonucleoprotein.通过递送Cas9核糖核蛋白进行基因组编辑。
Methods. 2017 May 15;121-122:9-15. doi: 10.1016/j.ymeth.2017.04.003. Epub 2017 Apr 12.
7
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery.使用Cas9核糖核蛋白和腺相关病毒（AAV）供体递送，通过同源定向基因组编辑进行靶向基因敲入。
Nucleic Acids Res. 2017 Jun 20;45(11):e98. doi: 10.1093/nar/gkx154.
8
CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein.使用Cas9蛋白对人类受精卵进行CRISPR/Cas9介导的基因编辑。
Mol Genet Genomics. 2017 Jun;292(3):525-533. doi: 10.1007/s00438-017-1299-z. Epub 2017 Mar 1.
9
First human experience with autologous Schwann cells to supplement sciatic nerve repair: report of 2 cases with long-term follow-up.首例自体雪旺细胞补充坐骨神经修复的人体经验：2例长期随访报告
Neurosurg Focus. 2017 Mar;42(3):E2. doi: 10.3171/2016.12.FOCUS16474.
10
Safety of Autologous Human Schwann Cell Transplantation in Subacute Thoracic Spinal Cord Injury.自体人雪旺细胞移植治疗亚急性胸段脊髓损伤的安全性。
J Neurotrauma. 2017 Nov 1;34(21):2950-2963. doi: 10.1089/neu.2016.4895. Epub 2017 Mar 21.
Zotero 插件